How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

52,558 results for

Topical Paste

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

52401. Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

defined as greater than 20 eosinophils per hpf on esophageal biopsy Ages 1 yrs and older Ability to continue the same diet that the patient was on at the time of EGD with biopsy Exclusion Criteria: Adverse reaction or allergy to budesonide Pregnancy Chronic diseases requiring immunomodulatory therapy Use of swallowed topical corticosteroids for EE within the past 3 months Use of systemic steroids 2 months prior to study entry Upper gastrointestinal bleed within 4 months of study entry Chronic use (...) Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Use of Topical

2008 Clinical Trials

52402. Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

, current tan, use of coumadin, aspirin , vitamin E or non-steroidal anti-inflammatory agents for the past 10 days. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 3 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal Study Start Date : February 2008 (...) Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical Imiquimod

2008 Clinical Trials

52403. Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer

or infection of the affected limb. Has a wound associated with prosthetic material or device. Received any topical or systemic antimicrobial therapy within the 2 weeks prior to study entry (Visit 1 [Day 1]). Has documented osteomyelitis. If severely immunocompromised, may be excluded at the discretion of the Investigator. Has a history of alcohol or substance abuse in the past 12 months. Is undergoing dialysis (renal or peritoneal) or has history of kidney transplant. Has history of myasthenia gravis (...) Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2008 Clinical Trials

52404. Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments

Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Randomized Study to Compare the Bioavailability of Two Fluticasone Propionate 0.005% Topical Ointments The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00803218 Recruitment Status : Completed First Posted : December 5, 2008 Last Update Posted : March 16

2008 Clinical Trials

52405. Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing Use of any (...) Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2008 Clinical Trials

52406. Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past 12 months prior to dosing Use of any (...) Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please

2008 Clinical Trials

52407. Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results (...) information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study

2008 Clinical Trials

52408. Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams

and clinical assessment, as judged by the Investigator Signed and dated informed consent form which meets all criteria of current FDA regulations Exclusion Criteria: History of allergy to systemic or topical corticosteroids Presence of any skin condition or coloration that would interfere with the placement of test sites or the response or assessment of skin blanching Presence of medical condition requiring regular treatment with prescription drugs Drug or alcohol addiction requiring treatment in the past (...) Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove

2008 Clinical Trials

52409. Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00803439 Recruitment Status : Completed First Posted : December 5, 2008 Last Update Posted : March 16, 2012 Sponsor

2008 Clinical Trials

52410. Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00800293 Recruitment Status : Completed First Posted : December 2, 2008

2008 Clinical Trials

52411. Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

of prescription topical therapy for atopic dermatitis (e.g., corticosteroids or retinoids) within the past 2 weeks. Use of any investigational therapy within the past 4 weeks. Pregnant females, females who are breast feeding, or females of childbearing potential who are not practicing an acceptable method of birth control (abstinence, birth control pill/patch, barrier with spermicidal jelly, IUD, etc.), as determined by the investigator. Acceptable contraception must be used during the entire study (...) Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2008 Clinical Trials

52412. Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00783965 Recruitment Status : Completed First

2008 Clinical Trials

52413. Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00782613 Recruitment Status : Terminated (Study has been termination early due to financial contraints.) First Posted : October 31

2008 Clinical Trials

52414. Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

, cytokines) Chemotherapeutic or cytotoxic agents; Investigational agent Treatment within the past 30 days with any of the following: Surgical excision Photodynamic therapy Curettage Topical corticosteroids Laser Dermabrasion Chemical peel Imiquimod 5% cream Topical retinoids 5-fluorouracil Masoprocol Pimecrolimus or tacrolimus Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using (...) Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2008 Clinical Trials

52415. A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy

A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved (...) studies (100). Please remove one or more studies before adding more. A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00774722 Recruitment Status : Completed First Posted : October 17, 2008

2008 Clinical Trials

52416. Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers

Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00764361 Recruitment Status : Completed First Posted : October 2, 2008 Results First Posted : April 5, 2012 Last Update Posted : April 7, 2017 Sponsor: NanoSHIFT

2008 Clinical Trials

52417. A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease

A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease (FP1198-001) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00744276 Recruitment Status : Completed First Posted : August 29, 2008 Last Update Posted : May 27, 2010

2008 Clinical Trials

52418. Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough

Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) one or more studies before adding more. Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00743990 Recruitment Status : Completed First Posted : August 29, 2008 Last Update Posted : November 24, 2017

2008 Clinical Trials

52419. Mechanisms of Skin Repair by Topical Estrogen

, and men, at least 50 years of age and any racial/ethnic type. Subjects must understand and sign the informed consent prior to participation. Subjects must be in generally good health. Subjects must be available for follow-up visits to comply with the requirements of the protocol. Not on estrogen replacement therapy within the past 3 months. No nonsteroidal anti-inflammatory drugs two weeks prior to study entry. No topical steroids two weeks prior to study entry. You must live within a reasonable (...) Mechanisms of Skin Repair by Topical Estrogen Mechanisms of Skin Repair by Topical Estrogen - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Mechanisms of Skin Repair by Topical Estrogen The safety

2005 Clinical Trials

52420. A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00096980 Recruitment Status : Completed First Posted : November 18, 2004 Last Update Posted : June 21, 2013 Sponsor: Genentech, Inc. Information provided by (Responsible Party

2004 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>